Canming Chen
Key Laboratory Of Breast Cancer In Shanghai
Shanghai, China
Shanghai, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Germline mutations of TP53 gene among Chinese families with high risk for breast cancer
Journal: Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics
Published: December 15, 2015
Pathological complete response as a surrogate for relapse-free survival in patients with triple negative breast cancer after neoadjuvant chemotherapy.
Journal: Oncotarget
Published: December 03, 2015
Identification of a comprehensive spectrum of genetic factors for hereditary breast cancer in a Chinese population by next-generation sequencing.
Journal: PloS one
Published: November 23, 2014
Prognostic and predictive value of Phospho-p44/42 and pAKT in HER2-positive locally advanced breast cancer patients treated with anthracycline-based neoadjuvant chemotherapy.
Journal: World journal of surgical oncology
Published: April 23, 2013
Efficacy and safety of docetaxel combined with oxaliplatin as a neoadjuvant chemotherapy regimen for Chinese triple-negative local advanced breast cancer patients. A prospective, open, and unicentric Phase II clinical trial.
Journal: American journal of clinical oncology
Published: August 08, 2012
Showing 1-9 of 9
Last Updated: 09/26/2026